KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Current Leases: 2019-2024

Historic Current Leases for Chemed (CHE) over the last 6 years, with FY2024 value amounting to $42.3 million.

  • Chemed's Current Leases fell 112.26% to $42.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.0 million, marking a year-over-year decrease of 112.26%. This contributed to the annual value of $42.3 million for FY2024, which is 950.17% up from last year.
  • As of FY2024, Chemed's Current Leases stood at $42.3 million, which was up 950.17% from $38.6 million recorded in FY2023.
  • In the past 5 years, Chemed's Current Leases ranged from a high of $42.3 million in FY2024 and a low of $36.2 million during FY2020
  • For the 5-year period, Chemed's Current Leases averaged around $38.8 million, with its median value being $38.6 million (2023).
  • Its Current Leases has fluctuated over the past 5 years, first crashed by 784.11% in 2020, then soared by 950.17% in 2024.
  • Annual analysis of 5 years shows Chemed's Current Leases stood at $36.2 million in 2020, then rose by 4.73% to $37.9 million in 2021, then increased by 2.86% to $39.0 million in 2022, then fell by 0.93% to $38.6 million in 2023, then grew by 9.5% to $42.3 million in 2024.
  • Its Current Leases stands at $42.3 million for FY2024, versus $38.6 million for FY2023 and $39.0 million for FY2022.